AKAM vs SILO · P/E 27, rev $2.17B vs rev $18.0K
Akamai Technologies Inc (AKAM) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. SILO currently screens at market cap $4.4M.
Not investment advice. Open the AKAM and SILO stock pages for the full models.
Not investment advice.